BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar PV, Jain NK. Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles. AAPS PharmSciTech 2007;8:17. [PMID: 17408217 DOI: 10.1208/pt0801017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Ghosh P, Bag S, Singha Roy A, Subramani E, Chaudhury K, Dasgupta S. Solubility enhancement of morin and epicatechin through encapsulation in an albumin based nanoparticulate system and their anticancer activity against the MDA-MB-468 breast cancer cell line. RSC Adv 2016;6:101415-29. [DOI: 10.1039/c6ra20441d] [Cited by in Crossref: 17] [Article Influence: 2.8] [Reference Citation Analysis]
2 Peng H, Liu X, Lv G, Sun B, Kong Q, Zhai D, Wang Q, Zhao W, Wang G, Wang D, Li H, Jin L, Kostulas N. Voriconazole into PLGA nanoparticles: Improving agglomeration and antifungal efficacy. International Journal of Pharmaceutics 2008;352:29-35. [DOI: 10.1016/j.ijpharm.2007.10.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
3 Devanand Venkatasubbu G, Ramasamy S, Ramakrishnan V, Kumar J. Nanocrystalline hydroxyapatite and zinc-doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin. 3 Biotech 2011;1:173-86. [PMID: 22611528 DOI: 10.1007/s13205-011-0021-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
4 Wang S, Gong G, Su H, Liu W, Wang Z, Li L. Self-assembly of plasma protein through disulfide bond breaking and its use as a nanocarrier for lipophilic drugs. Polym Chem 2014;5:4871. [DOI: 10.1039/c4py00212a] [Cited by in Crossref: 20] [Article Influence: 2.5] [Reference Citation Analysis]
5 El-gendy N, Selvam P, Soni P, Berkland C. Development of Budesonide Nanocluster Dry Powder Aerosols: Preformulation. Journal of Pharmaceutical Sciences 2012;101:3434-44. [DOI: 10.1002/jps.23197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
6 Taneja N, Singh KK. Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan. Int J Pharm 2018;536:82-94. [PMID: 29146538 DOI: 10.1016/j.ijpharm.2017.11.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012;157:168-82. [PMID: 21839127 DOI: 10.1016/j.jconrel.2011.07.031] [Cited by in Crossref: 791] [Cited by in F6Publishing: 722] [Article Influence: 71.9] [Reference Citation Analysis]
8 Helal DO, Rouatbi N, Han S, Tzu-Wen Wang J, Walters AA, Abdel-Mottaleb MMA, Kamel AO, Geneidi AS, Awad GAS, Al-Jamal KT. A Natural Protein Based Platform for the Delivery of Temozolomide Acid to Glioma Cells. Eur J Pharm Biopharm 2021:S0939-6411(21)00262-9. [PMID: 34678408 DOI: 10.1016/j.ejpb.2021.10.007] [Reference Citation Analysis]
9 Diab R, Jaafar-Maalej C, Fessi H, Maincent P. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration? AAPS J 2012;14:688-702. [PMID: 22767270 DOI: 10.1208/s12248-012-9377-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
10 Ibrahim N, Ibrahim H, Dormoi J, Briolant S, Pradines B, Moreno A, Mazier D, Legrand P, Nepveu F. Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy. Int J Pharm 2014;464:214-24. [PMID: 24412521 DOI: 10.1016/j.ijpharm.2014.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
11 El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res 2009;26:1752-63. [PMID: 19415471 DOI: 10.1007/s11095-009-9886-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
12 Gong G, Liu W, Wang S. Self-assembled albumin nanoparticles as a nanocarrier for aclacinomycin A. Nanotechnology 2016;27:465602. [PMID: 27749275 DOI: 10.1088/0957-4484/27/46/465602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Xiao Z, Liu W, Zhu G, Zhou R, Niu Y. A review of the preparation and application of flavour and essential oils microcapsules based on complex coacervation technology: Microcapsules based on coacervation technology. J Sci Food Agric 2014;94:1482-94. [DOI: 10.1002/jsfa.6491] [Cited by in Crossref: 121] [Cited by in F6Publishing: 75] [Article Influence: 13.4] [Reference Citation Analysis]
14 Berts I, Fragneto G, Porcar L, Hellsing MS, Rennie AR. Controlling adsorption of albumin with hyaluronan on silica surfaces and sulfonated latex particles. Journal of Colloid and Interface Science 2017;504:315-24. [DOI: 10.1016/j.jcis.2017.05.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Mendoza-dorantes T, Pal U, Vega-acosta J, Márquez-beltrán C. Encapsulation and surface charge manipulation of organic and inorganic colloidal substrates by multilayered polyelectrolyte films. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2013;434:253-9. [DOI: 10.1016/j.colsurfa.2013.05.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
16 El-Gendy N, Aillon KL, Berkland C. Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent. Int J Pharm 2010;391:305-12. [PMID: 20214960 DOI: 10.1016/j.ijpharm.2010.03.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
17 El-Gendy N, Gorman EM, Munson EJ, Berkland C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci 2009;98:2731-46. [PMID: 19130469 DOI: 10.1002/jps.21630] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
18 Pinto AF, Nascimento JMD, Sobral RVDS, Amorim ELCD, Silva RO, Leite ACL. Tannic acid as a precipitating agent of human plasma proteins. European Journal of Pharmaceutical Sciences 2019;138:105018. [DOI: 10.1016/j.ejps.2019.105018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Ghosh P, Singha Roy A, Chaudhury S, Jana SK, Chaudhury K, Dasgupta S. Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity. Int J Biol Macromol 2016;86:408-17. [PMID: 26820351 DOI: 10.1016/j.ijbiomac.2016.01.082] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]